2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a

2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH) is a photosensitiser chemical that is used in photodynamic therapy.[1]

2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
Names
Other names
Photochlor
Identifiers
CAS Number
3D model (JSmol)
Abbreviations HPPH
ChemSpider
PubChem CID
Properties
Chemical formula
C39H48N4O4
Molar mass 636.837 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

It is being developed under the brand name Photochlor.

Clinical trials

A phase I/II clinical trial started in 1997 for esophageal cancer.[2]

A phase II trial for non-small cell lung cancer is due to run from 2007 to 2011.[3]

References

  1. Lobel, J; MacDonald, IJ; Ciesielski, MJ; Barone, T; Potter, WR; Pollina, J; Plunkett, RJ; Fenstermaker, RA; Dougherty, TJ (2001). "2-1-hexyloxyethyl-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy". Lasers in surgery and medicine. 29 (5): 397–405. doi:10.1002/lsm.10001. PMID 11891727.
  2. Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors
  3. Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.